Plasma enhancement specialist signs multi-year research and development collaboration to exploit P2i's ion-mask technology
P2i, a nanoscale enhancer of products, has signed a multi-year collaborative deal with biotech specialist Eppendorf to investigate potential applications of its groundbreaking ion-mask cold plasma deposition technology.
"This is a landmark opportunity for P2i , establishing us in the laboratory consumables market place", said P2i's CEO, Graham Hine.
"Eppendorf has a long standing reputation for innovation and we are looking forward to working alongside their designers to enhance the product range with ion-mask technology".
"P2i's technology offers a new and exciting opportunity for us to further develop our products to meet the precise needs of our customers," added Eppendorf's vice president of portfolio management, Joerg Richter.
"Eppendorf leads the field in developing systems for life-science research laboratories and ion-mask enhancement can only help us extend that lead".
Ion-Mask works by applying a protective layer, just nanometres thick, over the entire surface of a product by means of an ionised gas or plasma.
This layer is molecularly bound to the surface and will not leach away.
The process brings numerous product enhancements compared with other surface treatments.
